HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation - Wikidata - wikimedia - TriplyDB

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation

http://www.wikidata.org/entity/Q36559594

about

The IFITM proteins inhibit HIV-1 infection Ubiquitin in the activation and attenuation of innate antiviral immunity Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways How SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest.Innate and Adaptive Immune Regulation During Chronic Viral Infections Negative regulation of interferon-β gene expression during acute and persistent virus infections Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha.CD56+ T cells inhibit HIV-1 infection of macrophages The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production Viral hijacking of the host ubiquitin system to evade interferon responses.RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3 The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase.Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.Microbial strategies for antagonizing Toll-like-receptor signal transduction.Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1 Disruption of Type I Interferon Induction by HIV Infection of T Cells.Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune response The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion.RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load Virus-host mucosal interactions during early SIV rectal transmission.HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer HIV-2 Vpx protein interacts with interferon regulatory factor 5 (IRF5) and inhibits its function.Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?Endogenous retroelements and autoimmune disease.Viral takeover of the host ubiquitin system.Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

P2860

Q24629626-748EE2FC-91D2-4069-A909-64E7C581C9FE Q26771789-4ABBDF7A-45EA-48BB-A3E5-3E7DCEAE7137 Q26778121-38CDAED9-3DED-4AD6-897B-FAA8467A9738 Q26783655-3A0708B8-6EE0-40F8-8ABA-12B19FAF134A Q27693229-44A7A461-1AC4-417C-B386-32BC45E522BD Q28079717-04AF3428-499F-49C6-8FF2-8003D0335427 Q28478468-89964C96-31E3-4CB9-BD5C-23D66429394D Q30671100-3D3E13E7-31CC-43DE-9BFE-E22E9C1C1DCE Q33631612-6C8535F9-1E02-4F7C-9F36-0324A5A5C225 Q33730835-3A34D17E-2F67-4E50-AB1F-EFD8FE59BD8E Q33891972-85C89DBE-A7A4-48DC-8DC3-67D81EC5D035 Q34009029-171D5A28-4A00-44EC-9FC4-07F87242DE28 Q34130663-268BE598-60E4-4254-8879-A5F12F6A2C45 Q34150344-3C6D64B6-8279-4D79-93F5-09D3DFE0D4EC Q34364911-FAA78C29-6E4D-4162-BE36-BC2A5109C4B0 Q34449547-ECF1F34D-7350-46F7-8DBC-A7B6E00C75CD Q34737736-8D82E48A-FC2C-4BF1-9430-21FA037C6FC0 Q35076546-BF524E7F-35EA-4C7C-A588-FA096C8DF0CB Q35076553-F9A2C5EC-7C82-45AA-AB44-F3C0A57109F1 Q35108874-56A06427-BC76-46F3-9CC4-BBEF18254FED Q35190533-1501F1B9-FC72-4FC3-A221-D2487ADC97E8 Q35745385-7C8E4B96-8791-428E-9304-7F49561CC455 Q35777137-A643FB68-6BC3-4EAA-BEC2-E899B819FE43 Q36172164-93071E42-A5BC-4AF0-A762-30C0F76B415D Q36246428-64D556CA-95EA-49C4-BB08-877F39AF57DD Q36342106-508B59E3-8B14-41F1-87CA-30284D65B650 Q36537806-362D9061-D046-462B-A2F2-2FC2CB2EC1CB Q36597749-80623D3F-72FF-4955-9A7E-3BDF6808A4A9 Q36608205-FE1D6BEB-B5E1-4DC3-8E47-55C55050FACA Q36731231-AFFA91AE-5CBC-435F-9C6E-51283AF276AB Q36904912-6A7D8252-4CCB-4735-AFA4-585F6B59B749 Q36911742-9F373562-81D2-4F8E-9058-A396EC19788E Q37168039-434509DB-F4CF-48AC-B555-54716BCBD0F1 Q37365391-0024B991-0DAA-48BA-94D4-E47FFA097514 Q37365399-E4625987-A300-44EB-B6B1-3065B1423A92 Q37691600-E0ED8E06-2A98-47E6-9ECD-567ACFE256E6 Q37728096-86FA9F62-5CE6-4A59-BC6F-B2037AFF239E Q37733696-ABF774A0-C0D3-4D21-9E57-147C1D30564D Q37918803-D1365208-2A37-45D1-94CA-844B6851A1EA Q37932423-F049B719-026E-439E-9791-3A04CD5F414A

P2860

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation

http://www.wikidata.org/entity/Q36559594

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@ast

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@en

type

label

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@ast

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@en

prefLabel

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@ast

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@en

P1433

Q36559594-5B8267D9-192F-4636-9CA5-55B43C8AC7F2

P1476

Q36559594-E2C48746-832C-46DC-8588-48FA16F6945E

P2093

Q36559594-0036E15E-939C-4100-BE54-E6023E15C5EC

Q36559594-0B745371-279C-4622-9834-9A48F4977F8E

Q36559594-0B95E916-3C5A-4A69-A72D-E1344B48F1C7

Q36559594-74BEB9B8-75F6-46AF-ABFF-92ED81FCAA50

Q36559594-79E6AE4A-E7AF-42DF-A23D-80AB2155C945

P2860

Q36559594-0134DCE3-7887-4115-B113-4B6C002EEB3B

Q36559594-013D76D6-C39C-493B-967E-48580AFF8F87

Q36559594-072D18CF-2CF9-4A5D-B02D-A0AF8350241A

Q36559594-08E118CC-7B1D-4821-A2D3-CF712315D707

Q36559594-0C5933AA-DB1A-4AC5-A608-607E4399FC50

Q36559594-0F76A452-E142-44FF-9798-502D8D7806CC

Q36559594-1A0464C2-3C3E-445C-843F-71230A68E9B3

Q36559594-1B7BC48B-5105-466F-B02E-EE228060C35C

Q36559594-1BE0515A-E7B5-46DD-854B-6C1CCA67737E

Q36559594-257419E4-5F9C-4C1C-8045-384351E20D90

P304

Q36559594-E1B2281F-DB11-4E78-960B-627AC473F687

P31

Q36559594-58C10949-7318-48E6-BE67-EC77647B2991

P356

Q36559594-B833714D-F6B9-4833-AA40-FCABB63FE508

P407

Q36559594-0CA01478-845B-473B-8A50-413D5A0ACA5F

P433

Q36559594-2A3765A1-E3AA-4108-885F-DDC7426D6ABC

P478

Q36559594-2F0E450D-1A9F-4852-BA48-7432364D2FBD

P50

Q36559594-B874ED11-D234-47A0-8218-B9A6740063DB

P577

Q36559594-6AFDA296-F984-44F7-B3DB-0F883F484767

P5875

Q36559594-88554C67-9BF2-4046-86AA-C0C8E41312FC

P698

Q36559594-06B6F6CA-7032-49F5-B540-A3E44447A58D

P932

Q36559594-B4FE5EE9-B7C5-487A-A2A8-2DAF444D911F

P356

J.VIROL.2007.10.042

P1433

P1476

HIV-1 accessory proteins VPR a ...... argeting IRF-3 for degradation

@en

P2093

Barbora Lubyova

http://www.w3.org/2001/XMLSchema#string

Heather Ezelle

http://www.w3.org/2001/XMLSchema#string

Klaus Strebel

http://www.w3.org/2001/XMLSchema#string

Paula M Pitha

http://www.w3.org/2001/XMLSchema#string

Tim Alce

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.

Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation

Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases

Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

Antiviral actions of interferons

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

The IRF family, revisited

P304

85-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2007.10.042

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

373

http://www.w3.org/2001/XMLSchema#string

P50

Atsushi Okumura

P577

2007-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5765573

http://www.w3.org/2001/XMLSchema#string

P698

18082865

http://www.w3.org/2001/XMLSchema#string

P932

2312338

http://www.w3.org/2001/XMLSchema#string